
HIV-1 RNA response to antiretroviral treatment in 1280 participants in the Delta Trial: an extended virology study
Author(s) -
J. P. Aboulker,
AG Babiker,
F Brun-Vézinet,
JH Darbyshire,
Phillipe Flandre,
Brian Gazzard,
Nunn Aj,
Ruth Goodall,
Ahmed Aber,
Keith Bragman,
A Breckenridge,
C Carbon,
Isabelle Charreau,
Geneviève Chêne,
Phil Collis,
David A. Cooper,
J Dormont,
P Fiddian,
Markus Flepp,
Goebel Fd,
M Hooker,
Joep M. A. Lange,
Ruedi Lüthy,
Tea Peto,
Peter Reiss,
M Séligmann,
Stone Ab,
Jeff Thomis,
Stefano Vella,
G Walckenaer,
Daniel Warrell,
Ivd Weller,
Richard B. Wilber,
Patrick Yéni,
Jane Yeo,
R Withnall,
Jaap Goudsmit,
Huraux Jm,
J van der Noorda,
Robin A. Weiss,
Charles A. Boucher,
Rob Schuurman,
Diane Descamps,
Don Jeffries,
Richard S. Tedder,
Jonathan Weber,
Corinne Krzyanowski,
Gerrit-Jan Weverling,
Delta Coordinating Comm,
Delta Virology Commg
Publication year - 1999
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-199901140-00008
Subject(s) - zidovudine , didanosine , zalcitabine , sida , lentivirus , viral load , medicine , virology , immunology , rna , viral disease , biology , human immunodeficiency virus (hiv) , biochemistry , gene
To assess changes in HIV RNA and their relationship to disease progression.